Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed. This update reflects backend versioning and does not change visible content or functionality.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedStudy status updated to Completed, replacing the previous Active, not recruiting status.SummaryDifference0.4%

- Check49 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedA minor site revision was applied, updating from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3; no substantive changes to study details are visible in the page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check107 days agoChange DetectedFooter shows a new revision label 'Revision: v3.3.3' and removal of the 'HHS Vulnerability Disclosure' entry; this is a minor maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.